Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 96.29%101.78M | ---- | 16.35%51.85M | ---- | -10.10%44.57M | ---- | -51.74%49.57M | ---- | -17.47%102.72M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 50.19%-48.14M | ---- | -210.66%-96.65M | ---- | -44.43%-31.11M | ---- | 0.16%-21.54M | ---- | -73.68%-21.57M |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -29.91%-3.54M |
| Impairment and provisions: | ---- | 55.75%183.13M | ---- | 152.55%117.58M | ---- | -57.23%46.56M | ---- | 563.33%108.85M | ---- | 980.31%16.41M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 41.42%379K |
| -Impairmen of inventory (reversal) | ---- | 62.37%-1.7M | ---- | -1,494.43%-4.5M | ---- | 112.65%323K | ---- | -147.34%-2.55M | ---- | 40.81%5.39M |
| -Impairment of trade receivables (reversal) | ---- | -259.82%-10.68M | ---- | 89.29%6.68M | ---- | -64.63%3.53M | ---- | 683.05%9.98M | ---- | 118.37%1.27M |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --4.58M |
| -Other impairments and provisions | ---- | 69.41%195.5M | ---- | 170.23%115.4M | ---- | -57.89%42.71M | ---- | 2,020.05%101.42M | ---- | 392.18%4.78M |
| Revaluation surplus: | ---- | -274.10%-1.36M | ---- | ---363K | ---- | ---- | ---- | -19.88%-2.37M | ---- | ---1.98M |
| -Other fair value changes | ---- | -274.10%-1.36M | ---- | ---363K | ---- | ---- | ---- | -19.88%-2.37M | ---- | ---1.98M |
| Asset sale loss (gain): | ---- | -23.53%52K | ---- | -26.88%68K | ---- | 2,225.00%93K | ---- | -83.33%4K | ---- | --24K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -23.53%52K | ---- | -26.88%68K | ---- | 2,225.00%93K | ---- | -83.33%4K | ---- | 168.57%24K |
| Depreciation and amortization: | ---- | 10.23%10.38M | ---- | 1.15%9.42M | ---- | 2.86%9.31M | ---- | -28.95%9.05M | ---- | -8.83%12.74M |
| Financial expense | ---- | -8.01%2.31M | ---- | -24.74%2.51M | ---- | 33.83%3.34M | ---- | 19.58%2.49M | ---- | -61.98%2.08M |
| Exchange Loss (gain) | ---- | 40.71%-2.56M | ---- | -144.22%-4.32M | ---- | 244.89%9.78M | ---- | 52.36%-6.75M | ---- | -317.42%-14.16M |
| Special items | ---- | -3,355.56%-3.11M | ---- | 92.41%-90K | ---- | 97.56%-1.19M | ---- | -3,955.14%-48.54M | ---- | -1,517.57%-1.2M |
| Operating profit before the change of operating capital | ---- | 203.10%242.47M | ---- | -1.65%80M | ---- | -10.39%81.34M | ---- | -0.81%90.77M | ---- | -31.37%91.51M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -71.19%-109.57M | ---- | -1,155.29%-64.01M | ---- | 94.54%-5.1M | ---- | -1,780.46%-93.35M | ---- | 51.42%-4.96M |
| Accounts receivable (increase)decrease | ---- | 190.85%109.76M | ---- | 445.03%37.74M | ---- | 90.97%-10.94M | ---- | -598.80%-121.07M | ---- | -50.28%24.27M |
| Accounts payable increase (decrease) | ---- | -348.07%-66.03M | ---- | 131.12%26.62M | ---- | -146.50%-85.54M | ---- | 326.19%183.95M | ---- | -277.30%-81.33M |
| prepayments (increase)decrease | ---- | -581.98%-107.03M | ---- | -217.89%-15.69M | ---- | 83.69%-4.94M | ---- | -290.93%-30.27M | ---- | --15.86M |
| Special items for working capital changes | ---- | 654.04%224.31M | ---- | -49.18%29.75M | ---- | 272.04%58.53M | ---- | -123.91%-34.02M | ---- | 446.36%142.29M |
| Cash from business operations | 74.39%119.48M | 211.34%293.91M | 68.96%68.51M | 183.03%94.4M | 242.67%40.55M | 936.57%33.35M | 46.27%-28.42M | -102.12%-3.99M | -183.05%-52.9M | 6.18%187.64M |
| Hong Kong profits tax paid | ---- | 61.84%-1.28M | ---- | 34.59%-3.34M | ---- | 58.56%-5.11M | ---- | -437.24%-12.33M | ---- | 301.60%3.66M |
| Other taxs | -408.86%-13.03M | -116.51%-13.88M | -55.68%-2.56M | -88.56%-6.41M | 1.38%-1.65M | -2.78%-3.4M | 88.97%-1.67M | -27.73%-3.31M | -621.08%-15.13M | 33.82%-2.59M |
| Interest paid - operating | 55.51%-827K | 8.01%-2.31M | 11.94%-1.86M | 24.74%-2.51M | -8.65%-2.11M | -33.83%-3.34M | -38.88%-1.94M | -19.58%-2.49M | 1.13%-1.4M | 61.98%-2.08M |
| Net cash from operations | 64.79%105.62M | 236.55%276.45M | 74.19%64.09M | 281.84%82.14M | 214.86%36.79M | 197.29%21.51M | 53.86%-32.03M | -111.85%-22.11M | -206.51%-69.43M | 12.75%186.62M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -23.72%18.98M | -50.19%48.14M | -47.13%24.88M | 210.66%96.65M | 805.48%47.06M | 44.43%31.11M | --5.2M | -0.16%21.54M | ---- | 73.68%21.57M |
| Decrease in deposits (increase) | ---- | 8,066.67%239K | ---- | 98.73%-3K | ---- | -101.27%-236K | ---- | 1,342.11%18.58M | ---- | 85.54%-1.5M |
| Sale of fixed assets | ---- | -35.71%45K | ---- | 677.78%70K | ---- | -94.16%9K | ---- | 366.67%154K | ---- | -96.34%33K |
| Purchase of fixed assets | ---- | 37.13%-2.44M | ---- | -38.73%-3.88M | ---- | 45.44%-2.79M | ---- | -104.35%-5.12M | ---- | -32.45%-2.51M |
| Recovery of cash from investments | ---- | --403.4M | ---- | ---- | ---- | 1,196.15%520.91M | 825.40%371.91M | -94.84%40.19M | -95.32%40.19M | 964.08%778.35M |
| Cash on investment | 88.25%-77.77M | -112.14%-1.07B | -536.44%-661.68M | -438.12%-502.17M | ---103.97M | -203.40%-93.32M | ---- | --90.25M | ---- | ---- |
| Other items in the investment business | -91.30%-924K | ---- | 81.31%-483K | ---- | -85.77%-2.58M | ---- | -106.24%-1.39M | ---- | 81.97%22.31M | ---- |
| Net cash from investment operations | 90.63%-59.72M | -50.47%-615.92M | -971.21%-637.28M | -189.83%-409.33M | -115.83%-59.49M | 175.18%455.68M | 501.17%375.72M | -79.20%165.59M | 138.16%62.5M | 973.79%795.96M |
| Net cash before financing | 108.01%45.9M | -3.75%-339.47M | -2,425.19%-573.19M | -168.56%-327.19M | -106.60%-22.7M | 232.58%477.19M | 5,060.78%343.68M | -85.40%143.48M | 92.97%-6.93M | 310.01%982.57M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 2.44%94.05M | 4.81%97.13M | 9.30%91.81M | -23.15%92.67M | -0.18%84M | 133.85%120.58M | 161.64%84.15M | 364.06%51.56M | --32.16M | 5.26%11.11M |
| Refund | 10.24%-90.25M | 11.66%-111M | 8.05%-100.55M | -39.92%-125.66M | -45.98%-109.35M | -78.95%-89.8M | -2,443.67%-74.91M | -375.41%-50.18M | ---2.95M | 97.74%-10.56M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --18M | --17.6M | ---- |
| Dividends paid - financing | -38.92%-98.04M | -34.57%-129.65M | -20.14%-70.57M | 8.01%-96.35M | -3.73%-58.74M | -6.23%-104.73M | 12.63%-56.63M | -17.39%-98.59M | ---64.82M | 11.29%-83.98M |
| Absorb investment income | ---- | -91.59%601K | ---- | -29.04%7.15M | ---- | --10.08M | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | -55.91%-13.02M | ---- | -16,268.63%-8.35M | ---- | 99.61%-51K | ---- | ---12.98M | ---- | ---- |
| Other items of the financing business | 17.91%-7.44M | ---- | -161.41%-9.06M | ---- | 68.14%-3.47M | ---- | -107.53%-10.88M | --7.42M | 90.95%-5.24M | ---- |
| Net cash from financing operations | -15.05%-101.68M | -18.63%-162.5M | -0.93%-88.38M | -92.68%-136.98M | -50.25%-87.56M | 23.54%-71.09M | -150.65%-58.28M | 1.36%-92.97M | 59.88%-23.25M | 83.30%-94.26M |
| Effect of rate | -239.97%-2.05M | -132.49%-434K | 9.52%1.46M | 111.40%1.34M | 2.14%1.33M | -221.67%-11.72M | -80.44%1.31M | -89.20%9.63M | 825.87%6.68M | 5,106.51%89.17M |
| Net Cash | 91.57%-55.78M | -8.14%-501.97M | -500.00%-661.57M | -214.30%-464.16M | -138.63%-110.26M | 704.02%406.1M | 1,045.75%285.41M | -94.31%50.51M | 80.72%-30.18M | 373.62%888.32M |
| Begining period cash | -29.48%1.2B | -21.36%1.7B | -21.36%1.7B | 22.25%2.17B | 22.25%2.17B | 3.51%1.77B | 3.51%1.77B | 133.04%1.71B | 133.04%1.71B | -30.76%734.74M |
| Cash at the end | 9.57%1.14B | -29.48%1.2B | -49.28%1.04B | -21.36%1.7B | -0.06%2.06B | 22.25%2.17B | 21.93%2.06B | 3.51%1.77B | 192.52%1.69B | 133.04%1.71B |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.